Therapeutic agent for dry eye syndrome accompanied by Sjogren's syndrome

A technology for Sjögren's syndrome and dry eye syndrome, applied in drug combinations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve problems such as non-recognition, susceptibility to infection, and increased intraocular pressure, and achieve the goal of improving epithelial damage Effect
CN107405334BActive Publication Date: 2021-05-25TEIKA PHARMA CO LTD
3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
TEIKA PHARMA CO LTD
Publication Date
2021-05-25

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition for treating dry eye associated with Sjögren's syndrome, containing Ozagrel or a pharmacologically acceptable salt thereof as an active ingredient. The pharmaceutical composition of the present invention plays an important role in the treatment of corneal and conjunctival epithelial injuries associated with dry eye syndrome of Sjögren's syndrome, which still tends to remain strongly after dripping general dry eye syndrome therapeutic drugs (such as artificial tears, etc.). Especially excellent therapeutic effect. Therefore, the pharmaceutical composition of the present invention is useful as a therapeutic pharmaceutical composition for dry eye syndrome accompanied by Sjogren's syndrome.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a pharmaceutical composition useful for the treatment of dry eye associated with Sjogren's syndrome.

[0002] More specifically, the present invention relates to a pharmaceutical composition useful for the treatment of dry eye associated with Sjögren's syndrome, comprising ozagrel or a pharmacologically acceptable salt thereof as an active ingredient. Background technique

[0003] In recent years, with the popularization of air conditioners and the increase of visual display terminal (VDT, visual display terminals) workers, etc., the number of patients with dry eye syndrome has increased rapidly. Therefore, the importance of dry eye treatment has increased (Non-Patent Document 1).

[0004] Sjögren's syndrome is known as an autoimmune disease of unknown cause accompanied by dry eye. Since Sjögren's syndrome is accompanied by a high degree of lymphocyte infiltration in lacrimal glands, salivary glands, etc., dry eye ass...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More